<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04944108</url>
  </required_header>
  <id_info>
    <org_study_id>NEOUNIPD</org_study_id>
    <nct_id>NCT04944108</nct_id>
  </id_info>
  <brief_title>LISA vs INSURE in Extremely Low Birth Weight Infants. A Manikin Study</brief_title>
  <official_title>Does LISA Change the Time of Device Positioning Compared to INSURE in Extremely Low Birth Weight Infants With RDS? A Crossover Randomized Controlled Manikin Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Padova</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital Padova</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is an unblinded, randomized, controlled, crossover (AB/BA) trial of surfactant treatment&#xD;
      with LISA vs. INSURE in a manikin simulating an extremely low birth weight infant.&#xD;
      Participants will be level III NICU consultants and residents. Randomization will be&#xD;
      performed using a computer-generated random assignment list. The primary outcome measure will&#xD;
      be the total time of device positioning. The secondary outcomes will be the success of the&#xD;
      first and the participant's satisfaction.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background: Although LISA offers some advantages in ventilation procedure and neonatal&#xD;
      outcomes over INSURE, the use of a catheter during LISA may have some drawbacks such as the&#xD;
      prolonged duration of the laryngoscopy needed to insert the device. This is likely to&#xD;
      aggravate the invasiveness of the procedure, resulting in stressful consequences such as&#xD;
      bradycardia, hypoxia and hemodynamic changes.&#xD;
&#xD;
      Objectives: i) time of device positioning, ii) success of the procedure of positioning the&#xD;
      device, iii) participant's satisfaction.&#xD;
&#xD;
      Methods: This is an unblinded, randomized, controlled, crossover (AB/BA) trial of surfactant&#xD;
      treatment with LISA vs. INSURE in a manikin simulating an extremely low birth weight infant.&#xD;
      Participants will be level III NICU consultants and residents. Randomization will be&#xD;
      performed using a computer-generated random assignment list. The primary outcome measure will&#xD;
      be the total time of device positioning. The secondary outcomes will be the success of the&#xD;
      first and the participant's satisfaction.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">July 1, 2021</start_date>
  <completion_date type="Anticipated">July 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">July 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time of device positioning</measure>
    <time_frame>10 minutes</time_frame>
    <description>Time needed for the correct positioning of the device (thin catheter or tracheal tube). In case of failure, total time will be the sum of time of all attempts.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Success of the procedure at the first attempt</measure>
    <time_frame>1 minute</time_frame>
    <description>It refers at the success of the device positioning during the first attempt</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Participant's satisfaction</measure>
    <time_frame>5 minutes</time_frame>
    <description>At the end of the procedure, all participants will be required to fill a 5-item questionnaire aimed to assess their perception on the procedure (Likert scale)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Respiratory Distress Syndrome</condition>
  <condition>Preterm Birth</condition>
  <condition>Surfactant Deficiency Syndrome Neonatal</condition>
  <arm_group>
    <arm_group_label>Surfactant administration with less invasive surfactant administration (LISA) approach</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will be randomized to administer surfactant in a preterm manikin by using the LISA approach (thin catheter)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Surfactant administration with intubation (INSURE) approach</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants will be randomized to administer surfactant in a preterm manikin by using the INSURE approach (tracheal tube)</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>LISA approach</intervention_name>
    <description>Participants will be randomized to administer surfactant in a preterm manikin by using the LISA approach (thin catheter) or the INSURE approach (tracheal tube)</description>
    <arm_group_label>Surfactant administration with less invasive surfactant administration (LISA) approach</arm_group_label>
    <other_name>INSURE approach</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Insure approach</intervention_name>
    <description>Participants will be randomized to administer surfactant in a preterm manikin by using the INSURE approach (tracheal tube)</description>
    <arm_group_label>Surfactant administration with intubation (INSURE) approach</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Level III NICU consultants and residents will be eligible to participate in the study.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  There are no exclusion criteria for this study.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Poliambulanza Breacia</name>
      <address>
        <city>Brescia</city>
        <country>Italy</country>
      </address>
    </facility>
    <contact>
      <last_name>Paolo Villani, MD</last_name>
      <phone>3316992042</phone>
      <email>paolo.villani@poliambulanza.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospital of Padova</name>
      <address>
        <city>Padova</city>
        <zip>35128</zip>
        <country>Italy</country>
      </address>
    </facility>
    <contact>
      <last_name>Daniele Trevisanuto, MD</last_name>
      <phone>3406632734</phone>
      <email>daniele.trevisanuto@unipd.it</email>
    </contact>
    <investigator>
      <last_name>Daniele Trevisanuto, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>June 21, 2021</study_first_submitted>
  <study_first_submitted_qc>June 21, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 29, 2021</study_first_posted>
  <last_update_submitted>June 30, 2021</last_update_submitted>
  <last_update_submitted_qc>June 30, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 6, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital Padova</investigator_affiliation>
    <investigator_full_name>Daniele Trevisanuto</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Distress Syndrome</mesh_term>
    <mesh_term>Respiratory Distress Syndrome, Newborn</mesh_term>
    <mesh_term>Premature Birth</mesh_term>
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Birth Weight</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

